AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Mexfib G 3mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Fibovil Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Mexfib G 3mg/500mg Tablet SR

Diabexe Duo 3mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, manifesting as sweating, dizziness, headache, and tremor. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks, juice) to counteract this. Alcohol consumption increases hypoglycemia risk and should be minimized. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count, liver function tests) are recommended.

Primary Ingredients of Mexfib G 3mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Mexfib G 3mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Mexfib G 3mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing. Consumption of the Mexfib G 3mg/500mg sustained-release tablet should coincide with a meal.

Common Side effects of Mexfib G 3mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Mexfib G 3mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Mexfib G 3mg/500mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Mexfib G 3mg/500mg Tablet SR works:

Mexfib G SR tablets (3mg/500mg) combine glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Mexfib G 3mg/500mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Mexfib G 3mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Mexfib G 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Caution is advised when prescribing Mexfib G 3mg/500mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Patients with severe kidney disease should not use Mexfib G 3mg/500mg SR tablets. A physician's consultation is recommended. Regular monitoring of renal function is prudent during treatment.

LiverLiverCAUTION

The extended-release formulation of Mexfib G (3mg/500mg) requires careful administration in individuals with hepatic impairment. Dosage modification of Mexfib G (3mg/500mg) may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, initiation of Mexfib G (3mg/500mg) typically begins with a reduced dosage; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Mexfib G 3mg/500mg Tablet SR :

Should you forget to take a Mexfib G 3mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mexfib G 3mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Mexfib G 3mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Mexfib G 3mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Mexfib G 3mg/500mg Tablet SR and seek immediate medical attention.
Mexfib G 3mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Mexfib G 3mg/500mg Tablet SR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Mexfib G 3mg/500mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 is recommended annually by some researchers.
Mexfib G 3mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Mexfib G 3mg/500mg SR tablets and alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effect, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Mexfib G 3mg/500mg Tablet...
68
MRP 79
13% off